Epithalon is one of the most common peptides people bring up when the conversation turns to long-term aging support, and it gets mentioned in sleep conversations too. Below is the course structure people actually run, how to cycle and stack it, and how it stacks up against DSIP if sleep specifically is what you're after.
Vial size isn't part of what follows, since the amount of bacteriostatic water you add sets your concentration either way. Our reconstitution calculator handles that math for whatever vial and target dose you're working with.
What it is
Epithalon, also written Epitalon, is a short synthetic peptide — four amino acids, Ala-Glu-Asp-Gly (AEDG) — sold as a research chemical, not an FDA-approved supplement or drug. It's sometimes confused with epithalamin, an older, related pineal extract with a much longer history of its own. They're not the same product, and if a vendor page or forum thread is leaning on decades of use to justify a dosing number, it's usually talking about epithalamin, not the synthetic peptide you're actually buying. Worth knowing before you take a dosing claim at face value.
What people use it for
Epithalon shows up most in two conversations: long-term aging support and sleep or circadian rhythm. The longevity angle is the bigger one — most people running a course are doing it for the aging-support story first, with any sleep change treated as a secondary, welcome side effect rather than the main goal. A smaller slice of interest overlaps with skin and general repair, usually stacked with GHK-Cu.
If sleep itself is what you're chasing, DSIP is the more direct fit — see the comparison below.
Formulations
Epithalon ships as a lyophilized (freeze-dried) powder that needs reconstitution before use. Vendors most commonly sell 10 mg and 20 mg vials, with 5 mg less common. There's no analog or extended-release version in circulation the way some peptides have, and no oral or nasal commercial formulation, so subcutaneous injection of the reconstituted solution is effectively the only route people run. Occasionally you'll see it sold pre-blended with GHK-Cu; treat those as two peptides in one vial rather than a distinct formulation, and confirm the milligram amount of each before comparing price.
Dosing protocols
There's no single settled dose for Epithalon. What circulates is a course structure that vendors and forums converged on over time, not a number that traces back to one clear source.
See the Epithalon research notes for more background before reading the dosing itself.
Standard course
The most commonly referenced pattern. Daily dose: 5 to 10 mg. Route: subcutaneous injection. Course length: 10 consecutive days. Repeat: 2 to 3 courses per year, spaced roughly 3 to 4 months apart.
Extended course
A less common variant. Daily dose: 5 to 10 mg. Route: subcutaneous injection. Course length: 20 consecutive days. Repeat: once or twice per year.
Course total, for planning your vial purchase: a 10-day course at 5 to 10 mg daily works out to 50 to 100 mg total, which is 5 to 10 full 10 mg vials, or 2.5 to 5 full 20 mg vials. Compare vendors on price per milligram against that total rather than against the price of a single vial.
Cycling guidelines
The course-then-rest structure is the convention across every version of this protocol — a short, defined window rather than continuous exposure. Two tiers show up: a 10-day course for general longevity and sleep interest, and a 20-day course for people weighting the longevity framing more heavily. Both are typically run 1 to 3 times a year rather than back to back.
Signs a course is commonly stopped early:
- Persistent injection-site reaction beyond mild, brief redness
- New or worsening headache that doesn't resolve within the course
- Any new symptom you can't otherwise explain
Stacking
Most popular stack: Epithalon and GHK-Cu.
Rationale: both sit in the longevity and skin-aging interest, with different roles — circadian and cellular-aging signaling for Epithalon, collagen and repair signaling for GHK-Cu.
Protocol as run: Epithalon on its own 10-day course as above, with GHK-Cu run separately or overlapping, since GHK-Cu is more often used on a continuous or longer intermittent schedule rather than a matched 10-day window.
Why it's paired: the two get marketed together constantly because they answer to the same audience, not because there's documentation of the combination. Treat it as two separate protocols run in the same general season, not one combined protocol.
Considerations: running two peptides at once makes it harder to know which one is behind any change you notice, which matters more for a course this short.
Lighter stacks: Epithalon alongside BPC-157 or TB-500 shows up in general longevity-and-recovery stacks, and alongside Sermorelin or CJC-1295 in the growth-hormone-adjacent longevity crowd. Both are rationale plus a loosely matched schedule, not protocols with any dedicated combination data.
Combinations to approach carefully: stacking Epithalon with other peptides also proposed to affect cell proliferation, without any medical monitoring, isn't something we found a safety rationale for anywhere, given the theoretical cancer question noted below.
Expected results timeline
During the course: nothing acute is expected, since this isn't a same-night compound the way DSIP is. Anything noticed in the first few days is more likely the injection routine itself, or placebo, than the peptide doing its thing.
Short-term (during to just after a course): this is where the sleep and energy reports cluster, self-reported and not measured.
Cumulative (across repeated courses): any real aging-marker change would only show up here, and it's the piece with the least real-world evidence behind it: the underlying data is cell and animal work, not people.
What to expect realistically: a compound with an interesting story behind it and not much to point to in terms of measured human outcomes. Sleep or energy changes during a course are the most commonly reported signal. A measurable biomarker change without lab testing isn't a reasonable expectation.
Administration technique
- The lyophilized powder is reconstituted with bacteriostatic water, at a concentration set by the reconstitution calculator for the target dose.
- The solution is swirled gently to dissolve rather than shaken, since agitation can degrade the peptide.
- The calculated volume is drawn into an insulin syringe.
- A subcutaneous site is chosen, commonly the abdomen, with sites rotated daily across the course.
- The skin is pinched and the injection given at roughly a 45-degree angle, held for a few seconds before withdrawal.
- Each injection is commonly logged by date, dose, and site, so a 10 or 20-day course doesn't rely on memory partway through.
Side effects and safety
Common: mild redness or irritation at the injection site.
Less common: headache, mild fatigue during a course, and reports of vivid dreams or shifted sleep timing.
What we don't know: there's no completed human safety data for Epithalon itself — what exists is animal and cell work. Treat that as an open question, not a settled one.
Contraindications: anyone with active cancer or a personal history of cancer should be especially cautious with this one. The mechanism people point to for Epithalon's longevity effects — reactivating an enzyme called telomerase — is also a pathway some cancers use. That's not a documented harm, it's a theoretical concern worth taking seriously precisely because it hasn't been studied either way. Pregnancy, breastfeeding, and use in minors all have no data behind them and should be avoided.
Drug interactions: none have been characterized. That's an absence of data, not evidence of safety.
Epithalon vs. DSIP
If you're weighing Epithalon against something else, DSIP is the one people actually cross-shop it against. Both get talked about in the same sleep-and-pineal-gland conversation, so it's worth being clear on how they differ before picking one.
| Epithalon | DSIP | |
|---|---|---|
| Main use case | Long-term aging support; sleep is a secondary interest | Sleep specifically — falling asleep and sleep quality |
| How it's typically run | Short cyclical courses (10 or 20 days), a few times a year | Evening dosing, timed to that night's sleep |
| What it's not for | Same-night sleep support — it isn't fast-acting | Long-term aging or cellular-longevity claims |
| Availability | Widely sold by research chemical vendors | Widely sold by research chemical vendors |
Choose Epithalon if: your main interest is the longevity and aging-support angle, and you're fine running a defined course a few times a year rather than something nightly.
Choose DSIP if: sleep itself, falling asleep, staying asleep, sleep quality, is the actual thing you're trying to fix, and you want something dosed the night you need it rather than a multi-day course.
Stacking the two: some people run them together during an Epithalon course, since DSIP's evening dosing doesn't overlap with the daily course structure. That's convention, not a documented combination. See the full Epithalon vs. DSIP comparison for a deeper side-by-side, and the DSIP research notes for pricing and vendor info.
Storage and handling
Lyophilized powder: refrigerate at 2 to 8°C; some vendors recommend freezer storage for holds longer than a few months. Typically stable 12 to 24 months when stored correctly, though lot-specific stability should come from the vendor's certificate of analysis, not a general rule.
Reconstituted solution: refrigerate, and plan to use it within the window your vendor specifies, generally within 28 days once water has been added. That 28-day figure comes from the same compounding-pharmacy standard used industry-wide for a bacteriostatic-water solution rather than anything specific to Epithalon, so a vendor stating a different window takes priority.
Signs of degradation:
- Cloudiness or visible particles in a solution that was previously clear
- Discoloration of the powder or reconstituted liquid
- A course that produces none of the previously noticed subjective effects, though this is a soft signal at best
FAQ
Epithalon or DSIP — which one do I actually want? If sleep itself is the goal, DSIP. If long-term aging support is the goal and any sleep change is a bonus, Epithalon.
How long is a typical course? Most commonly 10 days, sometimes extended to 20, run subcutaneously once daily.
How many courses a year do people run? Usually 1 to 3, spaced several months apart, rather than continuous use.
Can I take it orally? There's no commercial oral formulation and nothing to suggest oral works — what circulates is injectable.
Is it safe to combine with GHK-Cu? No documented combination exists. People run them in the same general period, not as a single combined protocol.
Does it help with sleep? That's the most commonly self-reported effect, but it's a secondary one — if sleep is your main goal, look at DSIP first.
Is there a cancer risk? It's a theoretical concern worth taking seriously, not a documented one — see Side effects and safety above.
How is it stored? Refrigerated as a powder, refrigerated and used within about 28 days once reconstituted.
What's the difference between a 10 mg and 20 mg vial for a course? Only the concentration and how many vials your course total requires — the reconstitution calculator handles the arithmetic either way.
Bottom line
Key dosing takeaways:
- 5 to 10 mg daily, subcutaneous, for a 10 or 20-day course, repeated 1 to 3 times a year, is the shape people actually run
- That course structure is convention, not a number anyone can point to one clear source for
- If sleep is the actual goal rather than long-term aging support, DSIP is the more direct fit; see the comparison above
Best practices:
- Comparing vendors by course total in milligrams, not by vial count, is where the real price differences show up
- Logging each injection keeps a 10 or 20-day course from relying on memory
- A rest period between courses is standard across every version of this protocol; there's no version that runs continuously
Works best for people who:
- Are drawn to the longevity and aging-support angle first, with any sleep change as a bonus
- Want a short, defined course rather than an open-ended daily routine
- Are comfortable with real uncertainty about long-term effects, since solid human data doesn't exist yet